United States Pharmaceuticals

Idenix Pharmaceuticals LLC (IDIX)

Track

Ticker: IDIX Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
BAUPOST GROUP LLC/MA Large shareholder
Transaction date
Purchase
Price
315.16
Quantity 6,617 -6.9%
Value US$4,485,967
Fanning Paul SVP, Human Resources Officer
Transaction date
Sale
Price
316.14
Quantity 27,950 +40.0%
Value US$3,604,616
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
104.09
Quantity 95,903 +21.7%
Value US$1,386,527
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
6.52
Quantity 493 +0.0%
Value US$3,214
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.80
Quantity 436 +0.0%
Value US$2,529
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.79
Quantity 883 +0.0%
Value US$5,113
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.46
Quantity 7,402 +0.0%
Value US$40,415
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.11
Quantity 11,433 +0.0%
Value US$58,423
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.10
Quantity 39 +0.0%
Value US$199
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.79
Quantity 3,093 +0.0%
Value US$11,722
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.17
Quantity 4,336 +0.0%
Value US$13,745
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.04
Quantity 232 +0.0%
Value US$705
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.97
Quantity 427 +0.0%
Value US$1,268
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.96
Quantity 8,960 +0.0%
Value US$26,522
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.90
Quantity 3,117 +0.0%
Value US$9,039
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.85
Quantity 1,321 +0.0%
Value US$3,765
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.78
Quantity 997 +0.0%
Value US$2,772
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.69
Quantity 997 +0.0%
Value US$2,682
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.56
Quantity 2,493 +0.0%
Value US$6,382
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.47
Quantity 366 +0.0%
Value US$904
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.41
Quantity 35,735 +0.1%
Value US$86,121
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.46
Quantity 9,197 +0.0%
Value US$50,216
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.11
Quantity 2,107 +0.0%
Value US$10,767
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
4.70
Quantity 20,228 +0.1%
Value US$95,072
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.79
Quantity 140 +0.0%
Value US$531
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.17
Quantity 1,146 +0.0%
Value US$3,633
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.95
Quantity 6,476 +0.0%
Value US$19,104
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.41
Quantity 11,236 +0.0%
Value US$27,079
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.80
Quantity 1,785,714 +5.7%
Value US$4,999,999
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.11
Quantity 206 +0.0%
Value US$1,053
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.88
Quantity 1,760 +0.0%
Value US$6,829
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.79
Quantity 860 +0.0%
Value US$3,259
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.96
Quantity 897 +0.0%
Value US$2,655
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.41
Quantity 17,270 +0.1%
Value US$41,621
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.46
Quantity 486 +0.0%
Value US$2,654
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
5.11
Quantity 1,332 +0.0%
Value US$6,807
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.79
Quantity 165 +0.0%
Value US$625
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.96
Quantity 44 +0.0%
Value US$130
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.64
Quantity 822 +0.0%
Value US$2,170
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.41
Quantity 14,234 +0.0%
Value US$34,304
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.79
Quantity 813 +0.0%
Value US$3,081
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
3.04
Quantity 91 +0.0%
Value US$277
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.96
Quantity 262 +0.0%
Value US$776
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.41
Quantity 36,048 +0.1%
Value US$86,876
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.41
Quantity 1,351 +0.0%
Value US$3,256
NOVARTIS AG Indirect 10% Owner
Transaction date
Purchase
Price
2.41
Quantity 1,872 +0.0%
Value US$4,512
HODGSON THOMAS R Non-Executive Director
Transaction date
Purchase
Price
2.12
Quantity 10,387 +22.2%
Value US$22,020
HODGSON THOMAS R Non-Executive Director
Transaction date
Purchase
Price
2.15
Quantity 15,000 +47.2%
Value US$32,250
HODGSON THOMAS R Non-Executive Director
Transaction date
Purchase
Price
2.12
Quantity 11,000 +52.9%
Value US$23,320
HODGSON THOMAS R Non-Executive Director
Transaction date
Purchase
Price
2.08
Quantity 8,613 +70.6%
Value US$17,915
HODGSON THOMAS R Non-Executive Director
Transaction date
Purchase
Price
2.05
Quantity 5,000 +69.4%
Value US$10,250
Weidenbruch John Ex. VP, Gen. Counsel and Secr. Officer
Transaction date
Purchase
Price
1.89
Quantity 20,000 +133.3%
Value US$37,800
NOVARTIS AG INDIRECT 10% OWNER
Transaction date
Purchase
Price
2.41
Quantity 3,431 +0.0%
Value US$8,269
NOVARTIS AG INDIRECT 10% OWNER
Transaction date
Purchase
Price
2.62
Quantity 2,451 +0.0%
Value US$6,422
NOVARTIS AG Indirect 10% owner
Transaction date
Purchase
Price
2.41
Quantity 5,444 +0.0%
Value US$13,120
NOVARTIS AG INDIRECT 10% OWNER
Transaction date
Purchase
Price
4.05
Quantity 4,747 +0.0%
Value US$19,225
NOVARTIS AG Large shareholder
Transaction date
Purchase
Price
2.93
Quantity 4,654 +0.0%
Value US$13,636
NOVARTIS AG Large shareholder
Transaction date
Purchase
Price
2.41
Quantity 924 +0.0%
Value US$2,227
Mayers Douglas L EVP and Chief Medical Officer Officer
Transaction date
Purchase
Price
4.45
Quantity 30,000 +inf%
Value US$133,500
Koppy Susan Sr. VP, Business and Corp Dev. Officer
Transaction date
Purchase
Price
3.84
Quantity 400 +160.0%
Value US$1,536
NOVARTIS AG Large shareholder
Transaction date
Purchase
Price
20.48
Quantity 365 +0.0%
Value US$7,475
Sommadossi Jean-Pierre President, CEO, Chairman Executive Director
Transaction date
Purchase
Price
9.13
Quantity 10,000 +0.5%
Value US$91,300
Koppy Susan Sr. VP, Business and Corp Dev. Officer
Transaction date
Purchase
Price
9.26
Quantity 200 +400.0%
Value US$1,852
NOVARTIS AG Large shareholder
Transaction date
Purchase
Price
16.23
Quantity 2,938 +0.0%
Value US$47,684
Pollard-Knight Denise Non-Executive Director
Transaction date
Sale
Price
20.61
Quantity 629,498 -67.6%
Value US$12,973,954
NOVARTIS AG Large shareholder
Transaction date
Purchase
Price
20.61
Quantity 3,939,131 +14.4%
Value US$81,185,490
HODGSON THOMAS R
Transaction date
Purchase
Price
14.00
Quantity 7,200 +20.5%
Value US$100,800
Corcoran Andrea Exec. VP, Legal and Admin.
Transaction date
Purchase
Price
14.00
Quantity 7,200 +12.8%
Value US$100,800
3.7
Sommadossi Jean-Pierre President, CEO, Chairman Executive Director
Transaction date
Purchase
Price
14.00
Quantity 6,364 +0.3%
Value US$89,096
3.2
Macdonald Guy Executive VP, Operations
Transaction date
Purchase
Price
14.00
Quantity 10,000 +inf%
Value US$140,000
1.4
Arkowitz David Chief Financial Officer
Transaction date
Purchase
Price
14.00
Quantity 8,000 +inf%
Value US$112,000
3.0
BARSHEFSKY CHARLENE
Transaction date
Purchase
Price
14.00
Quantity 20,000 +inf%
Value US$280,000
CRAMB CHARLES W JR
Transaction date
Purchase
Price
14.00
Quantity 7,200 +inf%
Value US$100,800
Egan James Sr. VP, Business and Corp Dev
Transaction date
Purchase
Price
14.00
Quantity 13,400 +6.2%
Value US$187,600
3.1
GADICKE ANSBERT Large shareholder
Transaction date
Sale
Price
14.00
Quantity 508,371 -9.6%
Value US$7,117,194
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-02-04 2014-01-31 B Purchase BAUPOST GROUP LLC/MA Large shareholder
6,617 -6.9%
315.16
US$4,485,967 		6,617 -6.9% 315.16 US$4,485,967
2012-03-20 2012-03-16 S Sale Fanning Paul

SVP, Human Resources

Officer
27,950 +40.0%
316.14
US$3,604,616 		27,950 +40.0% 316.14 US$3,604,616
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
95,903 +21.7%
104.09
US$1,386,527 		95,903 +21.7% 104.09 US$1,386,527
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
493 +0.0%
6.52
US$3,214 		493 +0.0% 6.52 US$3,214
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
436 +0.0%
5.80
US$2,529 		436 +0.0% 5.80 US$2,529
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
883 +0.0%
5.79
US$5,113 		883 +0.0% 5.79 US$5,113
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
7,402 +0.0%
5.46
US$40,415 		7,402 +0.0% 5.46 US$40,415
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
11,433 +0.0%
5.11
US$58,423 		11,433 +0.0% 5.11 US$58,423
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
39 +0.0%
5.10
US$199 		39 +0.0% 5.10 US$199
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
3,093 +0.0%
3.79
US$11,722 		3,093 +0.0% 3.79 US$11,722
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
4,336 +0.0%
3.17
US$13,745 		4,336 +0.0% 3.17 US$13,745
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
232 +0.0%
3.04
US$705 		232 +0.0% 3.04 US$705
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
427 +0.0%
2.97
US$1,268 		427 +0.0% 2.97 US$1,268
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
8,960 +0.0%
2.96
US$26,522 		8,960 +0.0% 2.96 US$26,522
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
3,117 +0.0%
2.90
US$9,039 		3,117 +0.0% 2.90 US$9,039
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
1,321 +0.0%
2.85
US$3,765 		1,321 +0.0% 2.85 US$3,765
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
997 +0.0%
2.78
US$2,772 		997 +0.0% 2.78 US$2,772
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
997 +0.0%
2.69
US$2,682 		997 +0.0% 2.69 US$2,682
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
2,493 +0.0%
2.56
US$6,382 		2,493 +0.0% 2.56 US$6,382
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
366 +0.0%
2.47
US$904 		366 +0.0% 2.47 US$904
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
35,735 +0.1%
2.41
US$86,121 		35,735 +0.1% 2.41 US$86,121
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
9,197 +0.0%
5.46
US$50,216 		9,197 +0.0% 5.46 US$50,216
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
2,107 +0.0%
5.11
US$10,767 		2,107 +0.0% 5.11 US$10,767
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
20,228 +0.1%
4.70
US$95,072 		20,228 +0.1% 4.70 US$95,072
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
140 +0.0%
3.79
US$531 		140 +0.0% 3.79 US$531
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
1,146 +0.0%
3.17
US$3,633 		1,146 +0.0% 3.17 US$3,633
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
6,476 +0.0%
2.95
US$19,104 		6,476 +0.0% 2.95 US$19,104
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
11,236 +0.0%
2.41
US$27,079 		11,236 +0.0% 2.41 US$27,079
2011-04-13 2011-04-13 B Purchase NOVARTIS AG

Indirect 10% Owner
1,785,714 +5.7%
2.80
US$4,999,999 		1,785,714 +5.7% 2.80 US$4,999,999
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
206 +0.0%
5.11
US$1,053 		206 +0.0% 5.11 US$1,053
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
1,760 +0.0%
3.88
US$6,829 		1,760 +0.0% 3.88 US$6,829
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
860 +0.0%
3.79
US$3,259 		860 +0.0% 3.79 US$3,259
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
897 +0.0%
2.96
US$2,655 		897 +0.0% 2.96 US$2,655
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
17,270 +0.1%
2.41
US$41,621 		17,270 +0.1% 2.41 US$41,621
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
486 +0.0%
5.46
US$2,654 		486 +0.0% 5.46 US$2,654
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
1,332 +0.0%
5.11
US$6,807 		1,332 +0.0% 5.11 US$6,807
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
165 +0.0%
3.79
US$625 		165 +0.0% 3.79 US$625
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
44 +0.0%
2.96
US$130 		44 +0.0% 2.96 US$130
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
822 +0.0%
2.64
US$2,170 		822 +0.0% 2.64 US$2,170
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
14,234 +0.0%
2.41
US$34,304 		14,234 +0.0% 2.41 US$34,304
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
813 +0.0%
3.79
US$3,081 		813 +0.0% 3.79 US$3,081
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
91 +0.0%
3.04
US$277 		91 +0.0% 3.04 US$277
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
262 +0.0%
2.96
US$776 		262 +0.0% 2.96 US$776
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
36,048 +0.1%
2.41
US$86,876 		36,048 +0.1% 2.41 US$86,876
2010-06-08 2010-06-08 B Purchase NOVARTIS AG

Indirect 10% Owner
1,351 +0.0%
2.41
US$3,256 		1,351 +0.0% 2.41 US$3,256
2010-02-26 2010-02-26 B Purchase NOVARTIS AG

Indirect 10% Owner
1,872 +0.0%
2.41
US$4,512 		1,872 +0.0% 2.41 US$4,512
2009-12-17 2009-12-16 B Purchase HODGSON THOMAS R Non-Executive Director
10,387 +22.2%
2.12
US$22,020 		10,387 +22.2% 2.12 US$22,020
2009-12-17 2009-12-15 B Purchase HODGSON THOMAS R Non-Executive Director
15,000 +47.2%
2.15
US$32,250 		15,000 +47.2% 2.15 US$32,250
2009-12-14 2009-12-14 B Purchase HODGSON THOMAS R Non-Executive Director
11,000 +52.9%
2.12
US$23,320 		11,000 +52.9% 2.12 US$23,320
2009-12-14 2009-12-11 B Purchase HODGSON THOMAS R Non-Executive Director
8,613 +70.6%
2.08
US$17,915 		8,613 +70.6% 2.08 US$17,915
2009-12-14 2009-12-10 B Purchase HODGSON THOMAS R Non-Executive Director
5,000 +69.4%
2.05
US$10,250 		5,000 +69.4% 2.05 US$10,250
2009-11-24 2009-11-24 B Purchase Weidenbruch John

Ex. VP, Gen. Counsel and Secr.

Officer
20,000 +133.3%
1.89
US$37,800 		20,000 +133.3% 1.89 US$37,800
2009-08-24 2009-08-21 B Purchase NOVARTIS AG

INDIRECT 10% OWNER
3,431 +0.0%
2.41
US$8,269 		3,431 +0.0% 2.41 US$8,269
2009-05-29 2009-05-29 B Purchase NOVARTIS AG

INDIRECT 10% OWNER
2,451 +0.0%
2.62
US$6,422 		2,451 +0.0% 2.62 US$6,422
2009-02-23 2009-02-23 B Purchase NOVARTIS AG

Indirect 10% owner
5,444 +0.0%
2.41
US$13,120 		5,444 +0.0% 2.41 US$13,120
2008-11-25 2008-11-19 B Purchase NOVARTIS AG

INDIRECT 10% OWNER
4,747 +0.0%
4.05
US$19,225 		4,747 +0.0% 4.05 US$19,225
2008-09-03 2008-09-02 B Purchase NOVARTIS AG Large shareholder
4,654 +0.0%
2.93
US$13,636 		4,654 +0.0% 2.93 US$13,636
2008-05-30 2008-05-29 B Purchase NOVARTIS AG Large shareholder
924 +0.0%
2.41
US$2,227 		924 +0.0% 2.41 US$2,227
2008-03-13 2008-03-11 B Purchase Mayers Douglas L

EVP and Chief Medical Officer

Officer
30,000 +inf%
4.45
US$133,500 		30,000 +inf% 4.45 US$133,500
2007-07-19 2007-07-13 B Purchase Koppy Susan

Sr. VP, Business and Corp Dev.

Officer
400 +160.0%
3.84
US$1,536 		400 +160.0% 3.84 US$1,536
2006-06-08 2006-06-06 B Purchase NOVARTIS AG Large shareholder
365 +0.0%
20.48
US$7,475 		365 +0.0% 20.48 US$7,475
2006-05-11 2006-05-09 B Purchase Sommadossi Jean-Pierre

President, CEO, Chairman

Executive Director
10,000 +0.5%
9.13
US$91,300 		10,000 +0.5% 9.13 US$91,300
2006-05-10 2006-05-08 B Purchase Koppy Susan

Sr. VP, Business and Corp Dev.

Officer
200 +400.0%
9.26
US$1,852 		200 +400.0% 9.26 US$1,852
2006-04-06 2006-04-04 B Purchase NOVARTIS AG Large shareholder
2,938 +0.0%
16.23
US$47,684 		2,938 +0.0% 16.23 US$47,684
2005-11-16 2005-11-14 S Sale Pollard-Knight Denise Non-Executive Director
629,498 -67.6%
20.61
US$12,973,954 		629,498 -67.6% 20.61 US$12,973,954
2005-11-02 2005-10-31 B Purchase NOVARTIS AG Large shareholder
3,939,131 +14.4%
20.61
US$81,185,490 		3,939,131 +14.4% 20.61 US$81,185,490
2004-07-29 2004-07-27 B Purchase
HODGSON THOMAS R
7,200 +20.5%
14.00
US$100,800 		7,200 +20.5% 14.00 US$100,800
2004-07-29 2004-07-27 B Purchase
Corcoran Andrea

Exec. VP, Legal and Admin.
7,200 +12.8%
14.00
US$100,800 		7,200 +12.8% 14.00 US$100,800
2004-07-29 2004-07-27 B Purchase
3.7
Sommadossi Jean-Pierre

President, CEO, Chairman

Executive Director
6,364 +0.3%
14.00
US$89,096 		6,364 +0.3% 14.00 US$89,096
2004-07-29 2004-07-27 B Purchase
3.2
Macdonald Guy

Executive VP, Operations
10,000 +inf%
14.00
US$140,000 		10,000 +inf% 14.00 US$140,000
2004-07-29 2004-07-27 B Purchase
1.4
Arkowitz David

Chief Financial Officer
8,000 +inf%
14.00
US$112,000 		8,000 +inf% 14.00 US$112,000
2004-07-29 2004-07-27 B Purchase
3.0
BARSHEFSKY CHARLENE
20,000 +inf%
14.00
US$280,000 		20,000 +inf% 14.00 US$280,000
2004-07-29 2004-07-27 B Purchase
CRAMB CHARLES W JR
7,200 +inf%
14.00
US$100,800 		7,200 +inf% 14.00 US$100,800
2004-07-29 2004-07-27 B Purchase
Egan James

Sr. VP, Business and Corp Dev
13,400 +6.2%
14.00
US$187,600 		13,400 +6.2% 14.00 US$187,600
2004-07-28 2004-07-27 S Sale
3.1
GADICKE ANSBERT
Large shareholder
508,371 -9.6%
14.00
US$7,117,194 		508,371 -9.6% 14.00 US$7,117,194
Explore more

More insider trading research around Idenix Pharmaceuticals LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America